CH627761A5 - Process for the preparation of 17 beta esters of testosterone and 5 alpha-dihydrotestosterone - Google Patents

Process for the preparation of 17 beta esters of testosterone and 5 alpha-dihydrotestosterone Download PDF

Info

Publication number
CH627761A5
CH627761A5 CH640477A CH640477A CH627761A5 CH 627761 A5 CH627761 A5 CH 627761A5 CH 640477 A CH640477 A CH 640477A CH 640477 A CH640477 A CH 640477A CH 627761 A5 CH627761 A5 CH 627761A5
Authority
CH
Switzerland
Prior art keywords
esters
acid
alkyl group
preparation
testosterone
Prior art date
Application number
CH640477A
Other languages
German (de)
English (en)
Inventor
Johannes Van Der Vies
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/691,103 external-priority patent/US4098802A/en
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of CH627761A5 publication Critical patent/CH627761A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH640477A 1976-05-28 1977-05-24 Process for the preparation of 17 beta esters of testosterone and 5 alpha-dihydrotestosterone CH627761A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/691,103 US4098802A (en) 1975-02-18 1976-05-28 Oral pharmaceutical preparation having androgenic activity

Publications (1)

Publication Number Publication Date
CH627761A5 true CH627761A5 (en) 1982-01-29

Family

ID=24775172

Family Applications (1)

Application Number Title Priority Date Filing Date
CH640477A CH627761A5 (en) 1976-05-28 1977-05-24 Process for the preparation of 17 beta esters of testosterone and 5 alpha-dihydrotestosterone

Country Status (12)

Country Link
JP (1) JPS52148060A (nl)
AR (1) AR214323A1 (nl)
BE (1) BE855163A (nl)
CH (1) CH627761A5 (nl)
DE (1) DE2723876C2 (nl)
DK (1) DK146096C (nl)
ES (1) ES459230A1 (nl)
FI (1) FI57597C (nl)
FR (1) FR2352832A1 (nl)
GB (1) GB1567515A (nl)
NL (1) NL7705790A (nl)
SE (1) SE425493B (nl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2415349A1 (en) * 2000-08-23 2002-02-28 Akzo Nobel N.V. Testosterone ester formulation for human use
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
GB0807605D0 (en) 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (zh) * 2013-03-15 2015-06-16 利波辛股份有限公司 用於口服之脂平衡的長鏈睪固酮酯
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
FR2352832B1 (nl) 1980-07-11
GB1567515A (en) 1980-05-14
ES459230A1 (es) 1978-11-16
FI57597C (fi) 1980-09-10
DE2723876A1 (de) 1977-12-15
SE7706235L (sv) 1977-11-29
JPS52148060A (en) 1977-12-08
FI57597B (fi) 1980-05-30
DK236877A (da) 1977-11-29
DK146096B (da) 1983-06-27
AR214323A1 (es) 1979-05-31
JPS6145637B2 (nl) 1986-10-08
FI771684A (nl) 1977-11-29
FR2352832A1 (fr) 1977-12-23
DK146096C (da) 1983-11-21
DE2723876C2 (de) 1986-10-30
BE855163A (fr) 1977-11-28
NL7705790A (nl) 1977-11-30
SE425493B (sv) 1982-10-04

Similar Documents

Publication Publication Date Title
DE2624025C2 (nl)
DE68928920T2 (de) Fettsäure-arzneimittel-konjugat zur verabreichung von arzneimitteln durch die blut-gehirn-schranke
DE69031033T2 (de) Verwendung von eicosapentaensäure zur behandlung der kachexie
US4083973A (en) Pharmaceutical preparation adapted for oral administration
DE69429513T2 (de) Polyphenolderivatzusammensetzungen und deren herstellung
DE2508615C2 (nl)
DE3438630A1 (de) Kombinierte fettsaeurezusammensetzung zur senkung des cholesterin- und triglycerid-blutspiegels
EP0241809A1 (de) Synergistische Kombination von Amantadin und Selegilin
DE2752695A1 (de) Steroidester
DE69806962T2 (de) FSNMU als entzündungshemmende Mittel in den oberflächen Geweben von Säugetieren
DE2414680C2 (de) Substituierte 2-Furancarbonsäuren und 2-Furancarbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE69431965T2 (de) Wirkstoff gegen fettsucht
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
DE2549783A1 (de) Triglyceride mit entzuendungshemmender wirkung
DE69421366T2 (de) Staurosporinderivate und Polyalkylenglykol-Glyceride enthaltende Arzneimittel
DE69517050T2 (de) Verfahren zur stabilisation der polyungesättigten fettsäuren und verwendung dieser stabilisierten produkten in therapie und in kosmetologie
CH641352A5 (de) 15-(hydroxy-, acyloxy- oder oxo-)steroide enthaltende mittel zur hemmung der biosynthese der mevalonsaeure.
LU84892A1 (fr) Komposition zur reduktion der sebumsekretion
DE2723876C2 (de) 17β-Ester von Testosteron
EP0369216B1 (de) Arzneimittelzubereitung aus Esterderivaten des Hecogenins und dessen Verwendung zur Behandlung von benigner Prostatahyperplasie
DE2948733A1 (de) Steroidspirothiazolidinderivate, verfahren zur herstellung derselben und diese enhaltende arzneimittel
DE1801750A1 (de) Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung
DE2252637A1 (de) Choleretische arzneimittel
DE2748291A1 (de) Triglyceride, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von entzuendungen
CH652303A5 (de) Verwendung von polyprenylderivaten fuer die herstellung eines mittels fuer die aeusserliche behandlung von wunden oder von suppositorien fuer die behandlung von wunden bei menschen und tieren.

Legal Events

Date Code Title Description
PL Patent ceased